Paster Anne-Mari
Insider CIK 1652863 · KZR · MORF 10% owner · TBIO 10% owner · REPL 10% owner · KRON 10% owner · THRX · NUVB 10% owner · LXEO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics, Inc. | C Conversion deriv | 2023-11-07 | 2023-11-09 | 14,999,999 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion deriv | 2023-11-07 | 2023-11-09 | 2,615,533 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | P Buy | 2023-11-07 | 2023-11-09 | 454,545 | $11.00 | $5.00M | 2,157,623 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion | 2023-11-07 | 2023-11-09 | 287,213 | — | $0 | 1,703,078 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion | 2023-11-07 | 2023-11-09 | 1,415,865 | — | $0 | 1,415,865 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 693,152 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 523,979 | — | $0 | 523,979 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-10-12 | 2021-10-14 | 187,500 | $16.00 | $3.00M | 711,479 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2021-04-01 | 2021-04-05 | 16,500 | — | $0 | 16,500 | SEC↗ |
| NUVB Nuvation Bio Inc. | C Conversion deriv | 2021-02-10 | 2021-02-12 | 8,130,097 | — | $0 | 0 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 500,000 | $10.00 | $5.00M | 28,212,373 | SEC↗ |
| NUVB Nuvation Bio Inc. | C Conversion | 2021-02-10 | 2021-02-12 | 8,130,097 | — | $0 | 27,712,373 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 0 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 1,304,563 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 1,522,484 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 1,376,313 | — | $0 | 3,001,984 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 366,299 | $16.15 | $5.92M | 3,368,283 | SEC↗ |
| KRON Kronos Bio, Inc. | P Buy | 2020-10-14 | 2020-10-16 | 450,000 | $19.00 | $8.55M | 3,818,283 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 1,606,220 | — | $0 | 1,625,671 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2020-04-01 | 2020-04-03 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-01 | 857,470 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-01 | 1,978,779 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion | 2019-07-01 | 2019-07-01 | 857,470 | — | $0 | 857,470 | SEC↗ |
| MORF Morphic Holding, Inc. | P Buy | 2019-07-01 | 2019-07-01 | 133,333 | $15.00 | $2.00M | 2,969,582 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion | 2019-07-01 | 2019-07-01 | 1,978,779 | — | $0 | 2,836,249 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2019-04-01 | 2019-04-03 | 13,500 | — | $0 | 13,500 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-25 | 25,000 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-25 | 101,896 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-25 | 259,366 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-25 | 100,000 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion deriv | 2018-07-24 | 2018-07-25 | 248,672 | — | $0 | 248,672 | SEC↗ |
| REPL Replimune Group, Inc. | P Buy | 2018-07-24 | 2018-07-25 | 266,667 | $15.00 | $4.00M | 266,667 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion | 2018-07-24 | 2018-07-25 | 1,013,547 | — | $0 | 4,854,783 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion | 2018-07-24 | 2018-07-25 | 994,688 | — | $0 | 1,261,355 | SEC↗ |
| REPL Replimune Group, Inc. | C Conversion | 2018-07-24 | 2018-07-25 | 2,579,881 | — | $0 | 3,841,236 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2018-07-19 | 2018-07-25 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,676,348 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,676,348 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,263,484 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 1,263,484 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 302,173 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 302,173 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,000,103 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,000,103 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,800,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,800,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 979,179 | — | $0 | 979,179 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 979,179 | — | $0 | 979,179 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 1,458,424 | — | $0 | 1,458,424 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 1,458,424 | — | $0 | 1,458,424 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 377,783 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 377,783 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 315,489 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 315,489 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 377,783 | — | $0 | 693,272 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 377,783 | — | $0 | 693,272 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 315,489 | — | $0 | 315,489 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 315,489 | — | $0 | 315,489 | SEC↗ |